Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
CSRA
Cancer
chemosensitivity
functional assay
personalized medicine
Journal
Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
11
2020
accepted:
16
05
2021
entrez:
14
10
2021
pubmed:
15
10
2021
medline:
8
2
2022
Statut:
epublish
Résumé
As complex and heterogeneous diseases, cancers require a more tailored therapeutic management than most pathologies. Recent advances in anticancer drug development, including the immuno-oncology revolution, have been too often plagued by unsatisfying patient response rates and survivals. In reaction to this, cancer care has fully transitioned to the "personalized medicine" concept. Numerous tools are now available tools to better adapt treatments to the profile of each patient. They encompass a large array of diagnostic assays, based on biomarkers relevant to targetable molecular pathways. As a subfamily of such so-called companion diagnostics, chemosensitivity and resistance assays represent an attractive, yet insufficiently understood, approach to individualize treatments. They rely on the assessment of a composite biomarker, the
Identifiants
pubmed: 34646385
doi: 10.7150/thno.55954
pii: thnov11p9538
pmc: PMC8490527
doi:
Substances chimiques
Biomarkers, Pharmacological
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
9538-9556Informations de copyright
© The author(s).
Déclaration de conflit d'intérêts
Competing Interests: CBMP and MVA are former employees of Oncomedics SAS. SGI and CLA are founders of Oncomedics SAS and have an equity position in the company. MM and NC declare no competing interests.
Références
Mol Clin Oncol. 2013 Jul;1(4):763-767
pubmed: 24649243
Int J Cancer. 2014 Mar 1;134(5):1102-11
pubmed: 23959905
Trends Cancer. 2020 May;6(5):419-431
pubmed: 32348737
Clin Cases Miner Bone Metab. 2009 Jan;6(1):17-24
pubmed: 22461093
Oncol Lett. 2010 Mar;1(2):345-349
pubmed: 22966306
Anticancer Res. 2001 Nov-Dec;21(6A):4083-6
pubmed: 11911296
J Clin Diagn Res. 2015 Mar;9(3):GE01-5
pubmed: 25954633
Cancer Res. 2014 Nov 15;74(22):6408-18
pubmed: 25267064
Nat Rev Drug Discov. 2013 Oct;12(10):743-55
pubmed: 24008432
Anticancer Res. 2002 Mar-Apr;22(2B):1145-9
pubmed: 12168915
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Nat Genet. 2015 Mar;47(3):209-16
pubmed: 25665006
Cancer Cell Int. 2019 Dec 18;19:341
pubmed: 31866766
EBioMedicine. 2020 Jan;51:102578
pubmed: 31862441
J Korean Med Sci. 2008 Oct;23(5):916-9
pubmed: 18955806
Reprod Toxicol. 2017 Jun;70:97-101
pubmed: 27832950
Ann Oncol. 2017 Oct 1;28(10):2595-2605
pubmed: 28945830
Clin Colorectal Cancer. 2013 Jun;12(2):122-7
pubmed: 23332421
Eur J Cancer. 1997 May;33(6):960-6
pubmed: 9291821
Nat Rev Cancer. 2015 Dec;15(12):747-56
pubmed: 26536825
Lancet Oncol. 2015 Oct;16(13):1324-34
pubmed: 26342236
J Clin Lab Anal. 2016 Nov;30(6):804-810
pubmed: 26991127
Leuk Lymphoma. 2013 Mar;54(3):528-34
pubmed: 22924433
Micromachines (Basel). 2016 Jul 28;7(8):
pubmed: 30404302
Clin Transl Sci. 2017 Mar;10(2):84-92
pubmed: 28121072
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Anticancer Res. 2017 May;37(5):2679-2682
pubmed: 28476844
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Gynecol Oncol. 2000 May;77(2):258-63
pubmed: 10785475
Nat Biotechnol. 2006 Aug;24(8):985-95
pubmed: 16900147
Cancer Med. 2016 Jul;5(7):1444-53
pubmed: 27073068
Nat Commun. 2015 Feb 27;6:6169
pubmed: 25721094
Br J Cancer. 2012 Jan 3;106(1):53-60
pubmed: 22068817
Nat Commun. 2017 Nov 20;8(1):1613
pubmed: 29151572
Cancer Invest. 1991;9(5):491-503
pubmed: 1933482
Transl Oncol. 2017 Apr;10(2):241-254
pubmed: 28199863
Prog Clin Biol Res. 1988;276:75-92
pubmed: 3174684
J Natl Compr Canc Netw. 2011 Jan;9(1):115-20
pubmed: 21233247
J Thorac Dis. 2012 Feb;4(1):40-7
pubmed: 22295166
J Korean Med Sci. 2010 May;25(5):684-90
pubmed: 20436702
Int J Oncol. 1997 Sep;11(3):449-55
pubmed: 21528231
Cytotechnology. 2010 Oct;62(5):381-8
pubmed: 20820914
Cancer. 2007 May 1;109(9):1829-35
pubmed: 17366594
Nat Protoc. 2020 Jan;15(1):15-39
pubmed: 31853056
Clin Cancer Res. 1995 Mar;1(3):305-11
pubmed: 9815986
Biomaterials. 2016 Nov;108:197-213
pubmed: 27639438
Anal Chem. 2019 Jul 16;91(14):8948-8957
pubmed: 31179686
Curr Treat Options Oncol. 2006 Mar;7(2):103-10
pubmed: 16455021
PLoS One. 2018 Mar 2;13(3):e0193498
pubmed: 29499048
PLoS One. 2015 May 29;10(5):e0122609
pubmed: 26024531
J Gynecol Oncol. 2009 Jun;20(2):96-100
pubmed: 19590720
Oncogene. 2020 Feb;39(9):2024-2026
pubmed: 31745295
Anticancer Res. 2013 Mar;33(3):1029-34
pubmed: 23482777
J Transl Med. 2011 Jun 20;9:94
pubmed: 21689426
Oncol Rep. 2009 Feb;21(2):499-505
pubmed: 19148528
Sci Rep. 2017 Jul 26;7(1):6600
pubmed: 28747710
Cancer Res Treat. 2011 Jun;43(2):117-23
pubmed: 21811428
Cancer Invest. 2008 May;26(4):426-30
pubmed: 18443964
Pleura Peritoneum. 2016 Sep 1;1(3):119-133
pubmed: 30911616
Oncol Lett. 2010 Sep;1(5):885-888
pubmed: 22966400
PLoS One. 2010 Apr 08;5(4):e10035
pubmed: 20386701
Indian J Cancer. 2007 Oct-Dec;44(4):142-6
pubmed: 18322356
J Natl Cancer Inst. 2012 Dec 5;104(23):1775-7
pubmed: 23213182
Anticancer Agents Med Chem. 2018;18(1):139-145
pubmed: 28425853
Nat Med. 2015 Nov;21(11):1318-25
pubmed: 26479923
Nature. 2016 Feb 25;530(7591):391
pubmed: 26911756
Cancer Res. 1998 Aug 1;58(15):3248-53
pubmed: 9699650
Br J Cancer. 2020 Mar;122(6):735-744
pubmed: 31894140
J Gynecol Oncol. 2010 Mar;21(1):45-9
pubmed: 20379447
NPJ Precis Oncol. 2020 Jul 27;4:18
pubmed: 32793806
Cancer. 1984 Mar 15;53(6):1240-5
pubmed: 6692313
Clin Cancer Res. 1995 Dec;1(12):1537-43
pubmed: 9815954
Gynecol Oncol. 2000 Mar;76(3):405-8
pubmed: 10684718
Mol Clin Oncol. 2017 Oct;7(4):637-641
pubmed: 28855997
PLoS One. 2013 Aug 28;8(8):e73215
pubmed: 24015297
Head Neck. 2002 May;24(5):437-42
pubmed: 12001073
PLoS One. 2019 Sep 10;14(9):e0222140
pubmed: 31504065
Arch Otolaryngol Head Neck Surg. 1994 Mar;120(3):288-92
pubmed: 8123238
PLoS One. 2012;7(12):e51754
pubmed: 23300565
Recent Results Cancer Res. 2003;161:48-61
pubmed: 12528798
Cancer Med. 2015 Sep;4(9):1309-21
pubmed: 26108357
Cancer. 2012 Oct 1;118(19):4877-83
pubmed: 22354845
Cancer Control. 2015 Apr;22(2):226-31
pubmed: 26068769
J Korean Neurosurg Soc. 2011 Nov;50(5):426-33
pubmed: 22259689
Sci Transl Med. 2019 Oct 9;11(513):
pubmed: 31597751
Anticancer Res. 2008 May-Jun;28(3B):1733-40
pubmed: 18630452
Asian Pac J Cancer Prev. 2012;13(2):689-92
pubmed: 22524797
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Int J Cancer. 2020 Jul 1;147(1):285-296
pubmed: 31970760
Br J Cancer. 1992 Jan;65(1):27-32
pubmed: 1310250
Oncotarget. 2015 Sep 22;6(28):25619-30
pubmed: 26296973
J Thorac Cardiovasc Surg. 2007 Feb;133(2):303-8
pubmed: 17258552
SLAS Discov. 2019 Jul;24(6):615-627
pubmed: 30817892
Anticancer Res. 2012 Aug;32(8):3581-6
pubmed: 22843949
Cell. 2018 Oct 18;175(3):751-765.e16
pubmed: 30318143
Scand J Gastroenterol. 2011 Jan;46(1):70-8
pubmed: 20695724
J Clin Oncol. 2011 Aug 20;29(24):3328-30
pubmed: 21788567
Oral Oncol. 2003 Oct;39(7):701-7
pubmed: 12907210
Adv Drug Deliv Rev. 2018 Jul;132:235-251
pubmed: 29935988
Anticancer Drugs. 1998 Jan;9(1):51-7
pubmed: 9491792
J Clin Oncol. 2004 Sep 1;22(17):3631-8
pubmed: 15289488
J Laryngol Otol. 2004 Feb;118(2):162-4
pubmed: 14979960
Future Sci OA. 2017 Mar 27;3(2):FSO190
pubmed: 28670477
Int J Cancer. 2002 Mar 20;98(3):450-5
pubmed: 11920599
J Turk Ger Gynecol Assoc. 2016 Jan 12;17(1):35-40
pubmed: 27026777
Biochem Biophys Res Commun. 2019 Sep 10;517(1):49-56
pubmed: 31303270
Anticancer Drugs. 2000 Apr;11(4):269-73
pubmed: 10898542
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):194-201
pubmed: 16445633
Am J Obstet Gynecol. 2010 Jul;203(1):68.e1-6
pubmed: 20227055
N Engl J Med. 1978 Jun 15;298(24):1321-7
pubmed: 77475
Gynecol Oncol. 1998 Sep;70(3):392-7
pubmed: 9790793
Am J Cancer Res. 2018 Aug 01;8(8):1642-1660
pubmed: 30210932
Lung Cancer. 2010 Jun;68(3):472-7
pubmed: 19660825
Blood. 1998 Aug 1;92(3):968-80
pubmed: 9680366
Trends Pharmacol Sci. 2017 Jan;38(1):41-54
pubmed: 27789023
J Intern Med. 2008 Sep;264(3):275-87
pubmed: 18793333
Anticancer Res. 2019 Jan;39(1):313-318
pubmed: 30591474
Mol Clin Oncol. 2017 Sep;7(3):327-335
pubmed: 28811897
Ann Intern Med. 1997 Jan 1;126(1):91-4
pubmed: 8992938
Cell Death Dis. 2018 Jun 18;9(7):716
pubmed: 29915308
Cancer Res Treat. 2005 Aug;37(4):223-7
pubmed: 19956518
Cancer Res. 2012 Aug 15;72(16):3901-5
pubmed: 22865459
J Cell Death. 2017 Feb 24;10:1179670717691251
pubmed: 28469473
Anticancer Res. 2011 Jan;31(1):139-45
pubmed: 21273591
Clin Cancer Res. 2006 Sep 15;12(18):5454-63
pubmed: 17000680
Int J Cancer. 2010 May 15;126(10):2437-47
pubmed: 19821489
J Clin Diagn Res. 2017 May;11(5):XC01-XC03
pubmed: 28658890
Nat Rev Rheumatol. 2018 Jun;14(6):354-362
pubmed: 29760435
Methods Mol Biol. 2011;731:259-83
pubmed: 21516414
Cancer Discov. 2017 Jun;7(6):586-595
pubmed: 28365644
Expert Opin Drug Metab Toxicol. 2019 Jan;15(1):15-23
pubmed: 30484335
Mod Pathol. 2020 Jan;33(1):4-17
pubmed: 31383961
Anticancer Res. 2017 Mar;37(3):1297-1303
pubmed: 28314295
Oncology. 1971;25(1):55-65
pubmed: 5090419
J Natl Cancer Inst. 2015 Jun 24;107(8):
pubmed: 26109105
J Vis Exp. 2015 Jul 15;(101):e53070
pubmed: 26274375
Immunity. 2020 Jan 14;52(1):55-81
pubmed: 31940273
Neoplasia. 2015 Jan;17(1):1-15
pubmed: 25622895
Anal Bioanal Chem. 2015 Nov;407(28):8433-43
pubmed: 26427501
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8234-E8243
pubmed: 28835536
BMC Cancer. 2014 Aug 20;14:603
pubmed: 25139788
Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):355-62
pubmed: 19131921
Cell. 2009 Sep 4;138(5):822-9
pubmed: 19737509
Cancer Radiother. 2019 Oct;23(6-7):666-673
pubmed: 31451357
Rom J Morphol Embryol. 2017;58(4):1257-1262
pubmed: 29556614
Br J Cancer. 2016 Oct 11;115(8):940-948
pubmed: 27575850
Gastric Cancer. 2014 Oct;17(4):630-7
pubmed: 24318670
Pharmacol Ther. 2016 Sep;165:79-92
pubmed: 27218886
Gynecol Oncol. 2001 Nov;83(2):334-42
pubmed: 11606094
Cancer Res. 2015 Mar 15;75(6):913-7
pubmed: 25724677
Oncotarget. 2017 Jan 31;8(5):8854-8866
pubmed: 27750219
Anticancer Res. 2016 Nov;36(11):6173-6178
pubmed: 27793948
Anticancer Res. 2014 Dec;34(12):7197-201
pubmed: 25503149
Nat Rev Cancer. 2019 Feb;19(2):97-109
pubmed: 30578414
Nat Biotechnol. 2016 Nov;34(11):1161-1167
pubmed: 27723727
Anticancer Drugs. 2007 Oct;18(9):1093-101
pubmed: 17704660
Methods Mol Biol. 2017;1606:19-36
pubmed: 28501991
PLoS Curr. 2015 Jul 13;7:
pubmed: 26213638
Cancer Res. 1983 Jan;43(1):258-64
pubmed: 6571706
Mutagenesis. 2008 May;23(3):183-90
pubmed: 18256034
Trends Cancer. 2016 Dec;2(12):706-712
pubmed: 28741518
Carcinogenesis. 2018 Oct 8;39(10):1245-1253
pubmed: 29982410
Int J Cancer. 2020 Apr 15;146(8):2078-2088
pubmed: 31479514
Clin Cancer Res. 2012 Oct 1;18(19):5314-28
pubmed: 22825584
Curr Protoc Toxicol. 2005;Chapter 18:Unit18.6
pubmed: 23045118
Anticancer Res. 2000 May-Jun;20(3B):2049-54
pubmed: 10928150
J Visc Surg. 2019 Oct;156(5):377-379
pubmed: 31466831
Cureus. 2015 Dec 21;7(12):e423
pubmed: 26848412
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Surg Today. 2018 Apr;48(4):380-387
pubmed: 28993901
J Surg Res. 2011 Apr;166(2):247-54
pubmed: 19691974
J Transl Med. 2012 Aug 08;10:162
pubmed: 22873358
Breast. 2008 Feb;17(1):19-26
pubmed: 17659874
Mol Clin Oncol. 2017 Dec;7(6):1021-1026
pubmed: 29285367
Int J Gen Med. 2009 Jul 30;2:1-4
pubmed: 20360879
Int J Pharm. 2017 Oct 5;531(1):143-152
pubmed: 28803938
Mol Cancer Ther. 2011 Aug;10(8):1311-6
pubmed: 21673092
J Transl Med. 2016 Jan 12;14:10
pubmed: 26791256
World J Gastroenterol. 2013 Oct 21;19(39):6683-8
pubmed: 24151399
Science. 2018 Feb 23;359(6378):920-926
pubmed: 29472484
Anticancer Res. 2008 Mar-Apr;28(2A):949-55
pubmed: 18507041
Oncol Lett. 2015 May;9(5):2374-2380
pubmed: 26137074
Nat Rev Drug Discov. 2015 Dec;14(12):812-3
pubmed: 26471367
Oral Oncol. 2007 Sep;43(8):749-56
pubmed: 17112769
Gastric Cancer. 2016 Apr;19(2):350-360
pubmed: 26385385